pancreaticcancertherapyindex

65 results found.

Top Stocks matching your search for "pancreatic cancer therapy index"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
SLRX

Salarius Pharmaceuticals Inc

-8.52%

$2.23 - $2.04

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Oct, 28, 2022

$SLRX “These initial data explain why we believ... See more

Oct, 28, 2022

$SLRX SP-3164 showed significant tumor growth &q... See more

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
HTGM

HTG Molecular Diagnostics Inc

-37.26%

$4.67 - $2.93

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 3, 2023

So brilliant to save people’s lives and stop cancer in its tracks.

Jan, 13, 2023

$HTGM $THER Ther good buy with 1$ soon Ther... See more

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
NUZE

Nuzee Inc

-11.23%

$12.35 - $10.96

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

No reviews available.

SLRX

Salarius Pharmaceuticals Inc

-8.52%

$2.23 - $2.04

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Oct, 28, 2022

$SLRX “These initial data explain why we believe SP-3164 is so exciting, with the potential to make a positive difference in the treatment of hematologic cancers.

Oct, 28, 2022

$SLRX SP-3164 showed significant tumor growth "inhibition" in in vivo studies including statistically significant improvement over the approved immunomodulatory drugs lenalidomide (Revlimid®) and pomalidomide (Pomalyst®)

HTGM

HTG Molecular Diagnostics Inc

-37.26%

$4.67 - $2.93

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 3, 2023

So brilliant to save people’s lives and stop cancer in its tracks.

Jan, 13, 2023

$HTGM $THER Ther good buy with 1$ soon Theralink.com Tests available for cancers and rppa tech for treatments Ther stock symbol

Jan, 11, 2023

$HTGM best tests on the market for cancer

Dec, 27, 2022

Plus it is expecting more positive catalysts in weeks and months: 5 year data for breast cancer, Canada approval, China commercialziation, and much more.

Dec, 13, 2022

$PBLA cheapest cancer therapy stock on the market, load-up!!

Dec, 12, 2022

$HTGM MGTA BIG ONE POSITIVE GENE THERAPY

NUZE

Nuzee Inc

-11.23%

$12.35 - $10.96

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

No reviews available.